skip to Main Content

Paradigm Shift in the Treatment of Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Pancreatic cancer is a disease of the elderly: the average age of patients is 72. In Austria, about 1,600 people are diagnosed each year. Since pancreatic cancer has no specific symptoms, it is not usually diagnosed until the tumor is locally advanced or has already metastasized. Once the tumor has metastasized, it is usually no longer treatable by surgery or radiotherapy. In addition, the drug therapy options available to date have not been very successful, especially not in older people.

This is where there might be a paradigm shift: a prospective, multi-center study shows that the combination of nab-paclitaxel and gemcitabine produces equally good treatment results in the over 70s as it does in younger people. In both patient groups, the disease could be controlled with the same frequency and for a comparable length of time, and the second-line treatment (a subsequently administered treatment) showed equally good results in both collectives as well. Read more . . . 


Back To Top